Stem Cells Translational Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.9 | Q1 | 84.4% | 1.588 | Q1 | 92.8% |
| 2024 | 4.9 | Q2 | 75.0% | 1.547 | Q1 | 92.6% |
| 2023 | 5.4 | Q1 | 66.7% | 1.401 | Q1 | 91.8% |
| 2022 | 6.0 | Q1 | 66.7% | 1.390 | Q1 | 92.1% |
| 2021 | 7.7 | Q3 | 66.7% | 1.412 | Q1 | 92.3% |
| 2020 | — | — | 1.781 | Q1 | 94.5% | |
| 2019 | — | — | 1.968 | Q1 | 95.5% | |
| 2018 | — | — | 2.145 | Q1 | 95.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2157-6580
ISSN
2157-6564
region
Western Europe
coverage
2012-2026